APRECIA Pharmaceuticals

Description

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause our performance to differ materially. These forward-looking statements reflect our current views about future events and are subject to risks, uncertainties and assumptions.

Aprecia Pharmaceuticals Company was founded in 2003 with the explicit goal of achieving commercial production rates for the unique pharmaceutical dosage forms made possible by 3DP. Since 2007, Aprecia has focused on applying 3DP to a new “fast-melt” formulation platform known as ZipDose® technology, which brings easy-to-swallow functionality to high-dose products that remain unaddressed by prior technologies.

“I’m excited to be back at Aprecia for a number of reasons, not the least of which is the rare opportunity to be the first at something and redefine a market—which is what our breakthrough 3DP product development and manufacturing system has the potential to do,” stated Wetherhold. “Aprecia’s technology is being used to enhance the delivery of gold-standard pharmaceutical products, thereby improving treatment adherence for certain patient populations.

Prasco, the Authorized Generic Company, is a privately held healthcare company located in Mason, Ohio. As the acknowledged category leader, Prasco has more Authorized Generic partnerships than any other company. Established brand companies rely on Prasco to bring their brand products to the generic marketplace as Authorized Generics, which offers alternatives to consumers and pharmacists. For more information, visit www.Prasco.com .

Company contacts

Products & services

Similar companies nearby